WallStSmart
BNR

Burning Rock Biotech Ltd

NASDAQ: BNR · HEALTHCARE · DIAGNOSTICS & RESEARCH

$17.00
+4.68% today

Updated 2026-04-30

Market cap
$222.76M
P/E ratio
P/S ratio
0.41x
EPS (TTM)
$-0.75
Dividend yield
52W range
$2 – $42
Volume
0.0M

Burning Rock Biotech Ltd (BNR) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201720182019202020212022202320242025
Revenue$111.17M$208.87M$381.68M$429.90M$507.86M$563.24M$537.43M$515.82M$524.87M
Revenue growth (YoY)+87.9%+82.7%+12.6%+18.1%+10.9%-4.6%-4.0%+1.8%
Cost of revenue$39.47M$73.81M$108.34M$115.98M$143.72M$183.20M$174.21M$153.42M$132.93M
Gross profit$71.70M$135.06M$273.33M$313.92M$364.15M$380.04M$363.23M$362.40M$391.94M
Gross margin64.5%64.7%71.6%73.0%71.7%67.5%67.6%70.3%74.7%
R&D$49.02M$105.30M$156.94M$263.94M$367.86M$421.87M$347.02M$232.29M$161.96M
SG&A$76.04M$88.30M$132.16M$293.80M$490.26M$568.28M$437.82M$261.64M
Operating income$-120.87M$-161.40M$-169.09M$-412.40M$-797.06M$-980.41M$-669.32M$-357.56M$-53.35M
Operating margin-108.7%-77.3%-44.3%-95.9%-156.9%-174.1%-124.5%-69.3%-10.2%
EBITDA$-99.55M$-135.87M$-128.81M$-373.26M$-746.50M$-856.31M$-517.90M$-270.23M$-43.05M
EBITDA margin-89.6%-65.0%-33.7%-86.8%-147.0%-152.0%-96.4%-52.4%-8.2%
EBIT$-120.87M$-160.54M$-160.17M$-406.57M$-794.26M$-980.41M$-651.30M$-322.43M$-53.35M
Interest expense$9.86M$17.95M$8.99M$667000.00$1.54M$11.16M$0.00$29182.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-131.28M$-177.50M$-168.34M$-407.24M$-796.70M$-971.23M$-653.69M$-346.63M$-53.84M
Net income growth (YoY)-35.2%+5.2%-141.9%-95.6%-21.9%+32.7%+47.0%+84.5%
Profit margin-118.1%-85.0%-44.1%-94.7%-156.9%-172.4%-121.6%-67.2%-10.3%